EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Targeting histone deacetylases for cancer therapy: Trends and challenges

Tao Liang, Fengli Wang, Reham M Elhassan, Yongmei Cheng, Xiaolei Tang, Wengang Chen, Hao Fang, Xuben Hou

Acta Pharmaceutica Sinica B · 2023-06 · 13 (6) · 2425-2463

DOI: 10.1016/j.apsb.2023.02.007 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Pharmaceutica Sinica B, 2023-06. Verfasst von Tao Liang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, the Second Hospital Affiliated Wannan Medical College, Wuhu 241000, China. Die Arbeit wurde bisher 221-mal zitiert (Crossref) und nennt 296 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Combination therapyHDACsMultitarget agentOncogenesisPROTACSelective inhibitor

Autor:innen und Institutionen

  • Department of Pharmacy, the Second Hospital Affiliated Wannan Medical College, Wuhu 241000, China.
  • Department of Medicinal Chemistry and Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
  • Department of Science and Education, Translational Medicine Center & Vascular Disease Research Center, the Second Hospital Affiliated Wannan Medical College, Wuhu 241000, China.
  • Clinical Pathogens Detection Engineering Center of Wuhu, Wuhu 241000, China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Liang, T., Wang, F., Elhassan, R. M., Cheng, Y., Tang, X., Chen, W., Fang, H., & Hou, X. (2023). Targeting histone deacetylases for cancer therapy: Trends and challenges. Acta Pharmaceutica Sinica B, 13(6), 2425-2463. https://doi.org/10.1016/j.apsb.2023.02.007

Vancouver

Liang T, Wang F, Elhassan RM, Cheng Y, Tang X, Chen W, et al. Targeting histone deacetylases for cancer therapy: Trends and challenges. Acta Pharmaceutica Sinica B. 2023;13(6):2425-2463. doi:10.1016/j.apsb.2023.02.007

BibTeX
@article{Liang2023,
  author = {Liang, Tao and Wang, Fengli and Elhassan, Reham M and Cheng, Yongmei and Tang, Xiaolei and Chen, Wengang and Fang, Hao and Hou, Xuben},
  title = {Targeting histone deacetylases for cancer therapy: Trends and challenges},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2023},
  volume = {13},
  number = {6},
  pages = {2425--2463},
  doi = {10.1016/j.apsb.2023.02.007}
}
Kostenlos starten →